Hologic (HOLX) Competitors

Edwards Lifesciences (NYSE:EW) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Do analysts rate EW or HOLX?

Edwards Lifesciences presently has a consensus target price of $79.45, indicating a potential upside of 5.50%. Hologic has a consensus target price of $84.62, indicating a potential upside of 47.72%. Given Hologic's higher probable upside, analysts plainly believe Hologic is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	1 Sell rating(s)	12 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.42
Hologic	0 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.41

Is EW or HOLX more profitable?

Edwards Lifesciences has a net margin of 72.93% compared to Hologic's net margin of 18.42%. Hologic's return on equity of 19.72% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	72.93%	19.40%	14.37%
Hologic	18.42%	19.72%	10.94%

Does the media prefer EW or HOLX?

In the previous week, Edwards Lifesciences had 10 more articles in the media than Hologic. MarketBeat recorded 39 mentions for Edwards Lifesciences and 29 mentions for Hologic. Hologic's average media sentiment score of 1.08 beat Edwards Lifesciences' score of 0.95 indicating that Hologic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	20 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Hologic	19 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings & valuation, EW or HOLX?

Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$5.25B	8.43	$4.17B	$7.00	10.76
Hologic	$4.04B	3.18	$789.50M	$3.17	18.07

Do institutionals and insiders believe in EW or HOLX?

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by insiders. Comparatively, 1.9% of Hologic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in EW or HOLX?

Edwards Lifesciences received 457 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 70.76% of users gave Edwards Lifesciences an outperform vote while only 69.32% of users gave Hologic an outperform vote.

Company	Underperform	Outperform
Edwards Lifesciences	Outperform Votes 1338 70.76%	Underperform Votes 553 29.24%
Hologic	Outperform Votes 881 69.32%	Underperform Votes 390 30.68%

Which has more risk and volatility, EW or HOLX?

Edwards Lifesciences has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

Summary

Edwards Lifesciences beats Hologic on 12 of the 19 factors compared between the two stocks.